Related Experiment Videos
Nystatin increases hepatic alkaline phosphatase activity.
Biochimica Et Biophysica Acta
|July 29, 1983
Summary
Nystatin administration significantly increases alkaline phosphatase activity in rat livers, requiring new protein synthesis. This effect is independent of glucocorticoid release, as shown by adrenalectomy studies.
Area of Science:
- Biochemistry
- Pharmacology
- Hepatology
Background:
- Alkaline phosphatase plays a role in various physiological processes.
- Understanding the regulation of hepatic alkaline phosphatase is crucial for liver health.
- Nystatin is an antifungal medication with potential effects beyond its primary use.
Purpose of the Study:
- To investigate the effect of nystatin on alkaline phosphatase activity in rat livers.
- To determine the role of de novo protein synthesis in nystatin-induced alkaline phosphatase activity.
- To elucidate whether glucocorticoid release mediates the effect of nystatin on hepatic alkaline phosphatase.
Main Methods:
- Intraperitoneal administration of nystatin to rats.
- Use of cycloheximide to inhibit de novo protein synthesis.
- Bilateral adrenalectomy to assess the role of glucocorticoids.
Main Results:
- Nystatin administration led to a significant increase in hepatic alkaline phosphatase activity.
- Inhibition of protein synthesis with cycloheximide abolished the nystatin-induced increase.
- Adrenalectomy did not affect the nystatin-mediated induction of alkaline phosphatase.
Conclusions:
- Nystatin induces hepatic alkaline phosphatase activity in rats.
- De novo protein synthesis is essential for this induction.
- The induction mechanism does not involve the release of glucocorticoids.